This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Richard G. Weleber, MD

Arch Ophthalmol. 1994;112(6):752-754.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

STARGARDT'S MACULAR dystrophy (SMD) was first described in 1909 by the German ophthalmologist Karl Stargardt.¹ The original report described seven patients from two families in whom a macular degeneration developed that had its onset present as a reduction in visual acuity, often with a normal fundus appearance, in the first or second decade of life. Male and female patients were equally affected. Their parents were normal and only the siblings were affected, suggesting an autosomal recessive inheritance. Eventually, atrophic macular lesions ensued, surrounded by a varying number of yellowish, deep retinal flecks. Visual fields were normal and none of the patients complained of night blindness. In a subsequent publication, Stargardt² described mild widening of the Rayleigh equation toward the red end on Nagel anomaloscope testing, even with 20/200 visual acuity, indicating that only mild color vision loss occurs despite severe loss of central vision. Rosehr³ found that . . . [Full Text PDF of this Article]

Author Affiliations
Portland, Ore

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?